UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating reissued by stock analysts at Royal Bank of Canada in a note issued to investors on Thursday, AnalystRatings.com reports. They presently have a $341.00 target price on the healthcare conglomerate’s stock. Royal Bank of Canada’s price target suggests a potential upside of 15.42% from the stock’s previous close.
A number of other research analysts also recently issued reports on the stock. ValuEngine downgraded shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, July 2nd. Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research report on Friday, June 5th. They set a “buy” rating and a $384.00 target price for the company. Stephens boosted their target price on shares of UnitedHealth Group from $310.00 to $325.00 and gave the company an “overweight” rating in a research report on Tuesday, June 2nd. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 27th. Finally, Deutsche Bank decreased their target price on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a research report on Thursday, April 16th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and twenty-two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $325.92.
Shares of UNH traded down $2.93 during trading hours on Thursday, reaching $295.43. 34,966 shares of the company traded hands, compared to its average volume of 3,325,792. The stock has a market capitalization of $282.96 billion, a P/E ratio of 20.63, a P/E/G ratio of 1.46 and a beta of 0.72. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.60. UnitedHealth Group has a 12-month low of $187.72 and a 12-month high of $315.84. The business has a fifty day moving average price of $296.08 and a 200-day moving average price of $282.76.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share for the quarter, beating analysts’ consensus estimates of $3.63 by $0.09. The firm had revenue of $64.40 billion for the quarter, compared to analyst estimates of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company earned $3.73 earnings per share. As a group, research analysts predict that UnitedHealth Group will post 16.27 EPS for the current fiscal year.
In other news, Director Stephen J. Hemsley sold 45,637 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the completion of the sale, the director now owns 1,013,122 shares of the company’s stock, valued at $292,903,701.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.80% of the stock is owned by insiders.
Several hedge funds have recently added to or reduced their stakes in UNH. Ellis Investment Partners LLC grew its stake in UnitedHealth Group by 6.6% during the 1st quarter. Ellis Investment Partners LLC now owns 568 shares of the healthcare conglomerate’s stock valued at $134,000 after acquiring an additional 35 shares in the last quarter. Sound View Wealth Advisors Group LLC grew its stake in UnitedHealth Group by 1.1% during the 1st quarter. Sound View Wealth Advisors Group LLC now owns 3,411 shares of the healthcare conglomerate’s stock valued at $851,000 after acquiring an additional 37 shares in the last quarter. Vista Investment Management grew its stake in UnitedHealth Group by 0.9% during the 1st quarter. Vista Investment Management now owns 4,082 shares of the healthcare conglomerate’s stock valued at $1,018,000 after acquiring an additional 38 shares in the last quarter. Arkadios Wealth Advisors grew its stake in UnitedHealth Group by 1.9% during the 1st quarter. Arkadios Wealth Advisors now owns 2,110 shares of the healthcare conglomerate’s stock valued at $526,000 after acquiring an additional 39 shares in the last quarter. Finally, Windsor Group LTD grew its stake in UnitedHealth Group by 0.9% during the 2nd quarter. Windsor Group LTD now owns 4,497 shares of the healthcare conglomerate’s stock valued at $1,326,000 after acquiring an additional 39 shares in the last quarter. 86.59% of the stock is owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: What is a Derivative?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.